Qingyu Shi
- Molecular Medicine top 0.5%
- Pharmacology top 5%
- Endocrinology top 2%
- Clinical Biochemistry top 5%
- Epidemiology
- Topics
- Antibiotic Resistance in Bacteria (19 papers)Antibiotics Pharmacokinetics and Efficacy (8 papers)Bacterial Identification and Susceptibility Testing (5 papers)
In The Last Decade
Qingyu Shi
25 papers receiving 654 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Molecular Medicine 586
- Pharmacology 250
- Endocrinology 188
- Clinical Biochemistry 134
- Epidemiology 132
Countries citing papers authored by Qingyu Shi
This map shows the geographic impact of Qingyu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyu Shi more than expected).
Fields of papers citing papers by Qingyu Shi
This network shows the impact of papers produced by Qingyu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyu Shi. The network helps show where Qingyu Shi may publish in the future.
Co-authorship network of co-authors of Qingyu Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Qingyu Shi. A scholar is included among the top collaborators of Qingyu Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyu Shi. Qingyu Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 8 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 10 | |
| 9 | 7 | |
| 10 | 6 | |
| 11 | 2 | |
| 12 | 89 | |
| 13 | 11 | |
| 14 | 11 | |
| 15 | 37 | |
| 16 | 11 | |
| 17 | 16 | |
| 18 | Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in Chinabreakdown → | 246 |
| 19 | 55 | |
| 20 | 88 |
About Qingyu Shi
Qingyu Shi is a scholar working on Molecular Medicine, Endocrinology and Applied Microbiology and Biotechnology, having authored 26 papers that have together received 661 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (19 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Bacterial Identification and Susceptibility Testing (5 papers). The work is most often cited by research in Molecular Medicine (586 citations), Applied Microbiology and Biotechnology (125 citations) and Endocrinology (188 citations). Qingyu Shi has collaborated with scholars based in China and Canada. Frequent co-authors include Fupin Hu, Renru Han, Dandan Yin, Shi Wu, Yan Guo, Yonggui Zheng, Rong Zhang, Dong Dong, Siquan Shen and Yang Yang. Their work appears in journals such as The Lancet, Clinical Microbiology Reviews and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.